Moderna to Provide up to 125 Million COVID-19 Vaccine Doses Globally in Early 2021

Moderna Inc. said Thursday that it is looking forward to having 100 million to 125 million doses of its experimental COVID-19 vaccine ready for the entire globe by the first quarter of 2021.